Four hundred consecutive total gastrectomies for gastric cancer: A single-institution experience

Archives of Surgery

Volumn 143, Issue 8, 2008, Pages 769-775

  Pacelli, Fabio ^a   Papa, Valerio ^a   Rosa, Fausto ^a   Tortorelli, Antonio Pio ^a   Sanchez, Alejandro Martin ^a   Covino, Marcello ^a   Bossola, Maurizio ^a   Doglietto, Giovanni Battista ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; INCIDENCE; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PALLIATIVE THERAPY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STOMACH CANCER; SURVIVAL RATE; TOTAL STOMACH RESECTION;

AGED; FEMALE; GASTRECTOMY; HUMANS; LYMPH NODE EXCISION; MALE; MIDDLE AGED; PALLIATIVE CARE; RETROSPECTIVE STUDIES; STOMACH NEOPLASMS; SURVIVAL ANALYSIS;

EID: 49949093049     PISSN: 00040010     EISSN: 15383644     Source Type: Journal    
DOI: 10.1001/archsurg.143.8.769     Document Type: Article

References (39)

1. Brennan MF. Current status of surgery for gastric cancer: a review. Gastric Cancer. 2005;8(2):64-70.
2. Lauren P. The two histological main types of gastric cancer carcinoma: diffuse and so-called intestinal-type carcinoma. Acta Pathol Microbiol Scand. 1965;64:31-49.
3. Borrmann R. Geschwulste des Magens und Duodenums. In: Henke F, Lubarsch O, eds. Handbuch der Speziellen Pathologischen Anatomie und Histologie. Vol 4. Berlin, Germany: J Springer; 1926:812-1054.
4. Greene FL, Page DL, Fleming ID, et al. AJCC Cancer Staging Manual. 6th ed. Chicago, IL: Springer-Verlag; 2002.
5. Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma: 2nd English edition. Gastric Cancer. 1998;1(1):10-24.
6. Siewert JR, Stein HJ. Classification of carcinoma of the oesophagogastric junction. Br J Surg. 1998;85(11):1457-1459.
7. Doglietto GB, Pacelli F, Caprino P, Bossola M, Di Stasi C. Pancreas-preserving total gastrectomy for gastric cancer. Arch Surg. 2000;135(1):89-94.
8. Jinnai D. Surgical treatment of stomach cancer: extensive excision of the lymph nodes, with special reference to radical surgery of stomach cancer [in Japanese]. Gan No Rinsho. March 1972(suppl):245-251.
9. Pinotti HW. Extrapleural approach to the esophagus through frenolaparotomy [in Portuguese]. AMB Rev Assoc Med Bras. 1976;22(2):57-60.
10. Bozzetti F, Marubini E, Bonfanti G, Miceli R, Piano C, Gennari L; Italian Gastrointestinal Tumor Study Group. Subtotal versus total gastrectomy for gastric cancer: five-year survival rates in a multicenter randomized Italian trial. Ann Surg. 1999;230(2):170-178.
11. Gouzi JL, Huguier M, Fagniez PL, et al. Total versus subtotal gastrectomy for adenocarcinoma of the gastric antrum: a French prospective controlled study. Ann Surg. 1989;209(2):162-166.
12. McCulloch P, Nita M, Kazi H, Gama-Rodrigues J. Extended versus limited lymph node dissection technique for adenocarcinoma of the stomach. Cochrane Database Syst Rev. 2004;4(4):CD001964.
13. Pacelli F, Sgadari A, Doglietto GB. Surgery for gastric cancer. N Engl J Med. 1999;341(7):538-539.
14. Bonenkamp JJ, Hermans J, Sasako M, et al; Dutch Gastric Cancer Group. Extended lymph-node dissection for gastric cancer. N Engl J Med. 1999;340(12):908-914.
15. Cuschieri A, Fayers P, Fielding J, et al; Surgical Cooperative Group. Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC randomized controlled surgical trial. Lancet. 1996;347(9007):995-999.
16. Sasako M. Principles of surgical treatment for curable gastric cancer. J Clin Oncol. 2003;21(23)(suppl):274s-275s.
17. Sano T, Sasako M, Yamamoto S, et al. Gastric cancer surgery: morbidity and mortality results from a prospective randomized controlled trial comparing D2 and extended para-aortic lymphadenectomy: Japan Clinical Oncology Group Study 9501. J Clin Oncol. 2004;22(14):2767-2773.
18. Siewert JR, Kestlmeier R, Busch R, et al. Benefit of D2 lymph node dissection for patients with gastric cancer and pN0 and pN1 lymph node metastases. Br J Surg. 1996;83(8):1144-1147.
19. Pacelli F, Doglietto GB, Bellantone R, Alfieri S, Sgadari A, Crucitti F. Extensive versus limited lymph node dissection for gastric cancer: a comparative study of 320 patients. Br J Surg. 1993;80(9):1153-1156.
20. Degiuli M, Sasako M, Calgaro M, et al; Italian Gastric Cancer Study Group. Morbidity and mortality after D1 and D2 gastrectomy for cancer: interim analysis of the Italian Gastric Cancer Study Group (IGCSG) randomized surgical trial. Eur J Surg Oncol. 2004;30(3):303-308.
21. Edwards P, Blackshaw JR, Lewis WG, Barry JD, Allison MC, Jones DR. Prospective comparison of D1 vs modified D2 gastrectomy for carcinoma. Br J Cancer. 2004;90(10):1888-1892.
22. Sasako M. Risk factors for surgical treatment in the Dutch Gastric Cancer Trial. Br J Surg. 1997;84(11):1567-1571.
23. Maruyama K, Sasako M, Kinoshita T, Sano T, Katai H, Okajima K. Pancreas-preserving total gastrectomy for proximal gastric cancer. World J Surg. 1995;19(4):532-536.
24. Mellière D. Variations of the hepatic arteries and the pancreatic junction: classification and incidence: arteriographic and surgical detection: effects on hepatic pedicle surgery, excision of the pancreas and pancreatic and liver grafts [in French]. J Chir (Paris). 1968;95(1):5-42.
25. Skandalakis LJ, Rowe JS Jr, Gray SW, Skandalakis JE. Surgical embryology and anatomy of the pancreas. Surg Clin North Am. 1993;73(4):661-697.
26. Csendes A, Burdiles P, Rojas J, Braghetto I, Diaz JC, Maluenda F. A prospective randomized study comparing D2 total gastrectomy versus D2 total gastrectomy plus splenectomy in 187 patients with gastric carcinoma. Surgery. 2002;131(4):401-407.
27. Yu W, Choi GS, Chung HY. Randomized clinical trial of splenectomy versus splenic preservation in patients with proximal gastric cancer. Br J Surg. 2006;93(5):559-563.
28. Ito H, Clancy TE, Osteen RT, et al. Adenocarcinoma of gastric cardia: what is the optimal surgical approach? J Am Coll Surg. 2004;199(6):880-886.
29. Stipa S, Di Giorgio A, Ferri M. Surgical treatment of adenocarcinoma of the cardia. Surgery. 1992;111(4):386-393.
30. Bozzetti F, Bignami P, Bertario L, Fissi S, Eboli M. Surgical treatment of gastric cancer invading the oesophagus. Eur J Surg Oncol. 2000;26(8):810-814.
31. Mariette C, Castel B, Balon JM, Van Seuningen I, Triboulet JP. Extent of oesophageal resection for adenocarcinoma of the oesophagogastric junction. Eur J Surg Oncol. 2003;29(7):588-593.
32. Schrock TR, Way LW. Total gastrectomy. Am J Surg. 1978;135(3):348-355.
33. Papachristou DN, Fortner JG. Adenocarcinoma of the gastric cardia: the choice of gastrectomy. Ann Surg. 1980;192(1):58-64.
34. Hallissey MT, Allum WH, Roginski C, Fielding JWL. Palliative surgery for gastric cancer. Cancer. 1988;62(2):440-444.
35. Korenaga D, Tsujitani S, Haraguchi M, et al. Long-term survival in Japanese patients with far advanced carcinoma of the stomach. World J Surg. 1988;12(2):236-240.
36. Doglietto GB, Pacelli F, Caprino P, et al. Palliative surgery for far-advanced gastric cancer: a retrospective study on 305 consecutive patients. Am Surg. 1999;65(4):352-355.
37. Pacelli F, Bossola M, Papa V, Sgadari A, Doglietto GB. Postoperative enteral versus parenteral nutrition. Lancet. 2002;359(9318):1697-1698.
38. Doglietto GB, Papa V, Tortorelli AP, Bossola M, Covino M, Pacelli F; Italian Total Gastrectomy Study Group. Nasojejunal tube placement after total gastrectomy: a multicenter prospective randomized trial. Arch Surg. 2004;139(12):1309-1313.
39. Concolino P, Papa V, Mozzetti S, et al. The unsolved enigma of CDH1 down-regulation in hereditary-diffused gastric cancer. J Surg Res. 2004;121(1):50-55.